Results 191 to 200 of about 21,178 (234)
Some of the next articles are maybe not open access.
The evaluation of gastric inhibitory polypeptide (GIP) as the enterogastrone
Journal of Surgical Research, 1979In 1886 Ewald and Boas [4] first showed that olive oil added to a test meal of starch paste given to human subjects inhibited both gastric emptying and acid secretion. Pavlov and his pupil Babkin (1928) later showed that this effect was of duodenal rather than of gastric origin.
P, Soon-Shiong, H T, Debas, J C, Brown
openaire +2 more sources
Gastric Inhibitory Polypeptide in Obesity and Diabetes Mellitus*
The Journal of Clinical Endocrinology & Metabolism, 1984Gastric inhibitory polypeptide (GIP) concentrations may be influenced by obesity, diabetes, and glucagon deficiency and be under feedback inhibition by insulin. To assess these factors, insulin-dependent diabetic, totally pancreatectomized diabetic, and lean and obese noninsulin-dependent diabetic patients were studied twice, once during partial ...
F J, Service +5 more
openaire +2 more sources
Gastric Inhibitory Polypeptide (GIP) in Chronic Pancreatitis
The Journal of Clinical Endocrinology & Metabolism, 1976The plasma gastric inhibitory polypeptide (GIP), pancreatic glucagon-like immunoreactivity (PGLI), and gut glucagon-like immunoreactivity (GGLI) responses to oral glucose have been measured in five patients with chronic pancreatitis (with diabetic glucose tolerance tests) and in matched nondiabetic controls. Plasma GIP levels rise rapidly after glucose
J L, Botha, A I, Vinik, J C, Brown
openaire +2 more sources
Glucagon, gastric inhibitory polypeptide and the gastrocolic response
The American Journal of Surgery, 1982Serosal bipolar electrodes and strain gauge force transducers were placed on the right and left colon in subhuman primates to record spike discharges and circular muscular contractions. The effect of glucagon on colonic motor and electrical activity were studied before and after meals.
J A, Strom +4 more
openaire +2 more sources
Gastric inhibitory polypeptide does not inhibit gastric emptying in humans
American Journal of Physiology-Endocrinology and Metabolism, 2004The insulinotropic gut hormone gastric inhibitory polypeptide (GIP) has been demonstrated to inhibit gastric acid secretion and was proposed to possess “enterogastrone” activity. GIP effects on gastric emptying have not yet been studied. Fifteen healthy male volunteers (23.9 ± 3.3 yr, body mass index 23.7 ± 2.3 kg/m2) were studied with the intravenous
Meier, Juris J +7 more
openaire +3 more sources
Gastric inhibitory polypeptide and gastric acid secretion in pregnant rats
Placenta, 1995The effects of pregnancy on the basal and pentagastrin-stimulated gastric acid secretion and the level of plasma gastric inhibitory polypeptide (GIP) in rats were studied on pentobarbital-anaesthetized non-pregnant rats and rats in the 1st, 2nd, or 3rd week of gestation. Acid output was determined by titration of the gastric perfusate.
T S, Chen +9 more
openaire +2 more sources
Gastric Inhibitory Polypeptide in the brain
2009The hippocampus is an area of active cell proliferation and neurogenesis within the adult mammalian brain. Adult neurogenesis is of great importance for the brain, since it increases neuroplasticity and the ability to respond to environmental stimuli. It also provides a possible mechanism for the brain to replace lost cells that have died due to injury
openaire +1 more source
Development of a radioimmunoassay for gastric inhibitory polypeptide
2010to evaluate the GIP response to feeding and oral glucose tolerance tests. Initial evidence for the insulinotropic action of GIP was presented. Indicated also was an implication of GIP involvement in various pathological conditions.
openaire +1 more source